Comparison of deflazacort and prednisone in Duchenne muscular dystrophy

Iranian Journal of Child Neurology

Volumn 6, Issue 1, 2012, Pages 5-12

  Karimzadeh, Parvaneh ^a   Ghazavi, Ahad ^b  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b URMIA UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Deflazacort; Duchenne muscular dystrophy; Prednisone

Indexed keywords

CALCIUM; DEFLAZACORT; PREDNISONE; VITAMIN D;

ARTICLE; BODY WEIGHT; CARDIOMYOPATHY; CATARACT; CHILD; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG DOSE REDUCTION; DUCHENNE MUSCULAR DYSTROPHY; GLUCOSURIA; HUMAN; MOTOR PERFORMANCE; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SCOLIOSIS; SIDE EFFECT; SINGLE BLIND PROCEDURE; TREATMENT DURATION; BLOOD PRESSURE; CORTICOSTEROID THERAPY; FOLLOW UP; HEART EJECTION FRACTION; LUNG CAPACITY; MALE; SCORING SYSTEM; SINGLE DRUG DOSE; STANDING; VITAMIN SUPPLEMENTATION; WALKING; WEIGHT GAIN;

EID: 84860990938     PISSN: 17354668     EISSN: 20080700     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Lankester BJA, Whitehouse MR, Gargan MF. Duchenne muscular dystrophy. Current Orthopedics 2007;21:298-300.
2. Wenger DR, Rang M. The art and practice of children's orthopedics. Philadelphia, PA: Lippincott; Baltimore: Williams and Wilkins; 1993.
3. Sussman M. Duchenne muscular dystrophy. J Am Acad Orthop Surg 2002 Mar-Apr;10(2):138-51.
4. Escolar DM, Leshner RT. Muscular dystrophies. In: Swaiman KF, Ashwal S, Ferriero DM. Pediatrie Neurology. 4thed.Philadelphia:Mosby;2006.p. 1967-86.
5. Sarnat HB, Menkes JH. Disease of the motor unit. In: Menkes JH, Sarnat HB, editors. Child Neurology. 7th ed. Philadelphia: Lippincott Williams & Wilkins; 2005. p. 984-9.
6. Biggar WD, Politano L, Harris VA, Passamano L, Vajsar J, Alman B, et al. Deflazacort in duchenne muscular dystrophy: a comparison of two different protocols. Neuromuscul disord 2004 Sep;14(8-9):476-82.
7. Radley HG, De Luca A, Lynch GS, Grounds MD. Duchenne muscular dystrophy: focus on pharmaceutical and nutritional interventions. Int J Biochem Cell Biol 2007;39(3):469-77.
8. Biggar WD, Klamut HJ, Demacio PC, Stevens DJ. Duchenne muscular dystrophy: current knowledge, treatment and future prospects. Clin Orthop Relat Res 2002Aug;401:88-106.
9. Sohn RL, Gussoni E. Stem cell therapy for muscular dystrophy. Expert Opin Biol Ther 2004 Jan;4(l): 1-9.
10. Houde S, Filiatrault M, Fournier A, Dube J, D'Arcy S, Berube D et al. Deflazacort use in duchenne muscular dystrophy: an 8-year follow-up. Pediatr Neurol 2008 Mar;38(3):200-6.
11. Bonifati MD, Ruzza G, Bonometto P, Berardinelh A, Gorni K, Orcesi K et al. A multicenter double-bind randomized trial of deflazacort versus prednisone in Duchenne muscular dystrophy: analysis after 2 years. Basic Appl Myol 2000;10:171-5.
12. Reitter B. Deflazacort vs. prednisone in Duchenne muscular dystrophy: trends of an ongoing study. Brain Dev 1995;17 Suppl:39-43.
13. Polgar G, Promadhat V. Standard values. In: pulmonary function testing in children: techniques and standards. Philadelphia: W.B. Saunders, 1971:102-3.
14. Biggar WD, Gingras M, Febling DL, Harris VA, Steele CA. Deflazacort treatment of Duchenne muscular dystrophy. J Pediatr 2001 Jan;138(l):45-50.